PMHNP Practice Authority in West Virginia: Independence, Physician Agreements and Schedule II

AANP's May 2026 map puts West Virginia in its reduced tier.

The label is AANP's advocacy classification; the legal fact behind it is that prescriptive authority issues under the terms of a collaborative agreement with a physician.

Read the statute whole, though: the same article that starts every PMHNP in an agreement also defines the way out, because subsection (e) directs the board to authorize prescribing without a collaborative agreement once an applicant has practised at least three years in a duly-documented collaborative relationship with granted prescriptive authority, is licensed in good standing and applies with the fee — so for prescribing the agreement is not framed as career-long, though a complaint-process order under (f) can re-impose one.

What never changes is the drug list in § 30-7-15a, which applies to every authorizing APRN.

The gate is precise: the applicant must have practised at least three years in a duly-documented collaborative relationship with granted prescriptive authority — so the clock runs on documented, board-authorized collaborative prescriptive practice, not on licensure alone.

A new graduate starts counting from their first authorized collaborative post.

The exit is a shall-grant: once the three years, good standing and a completed application with fee are in, the board shall authorize prescribing without the further requirement of a collaborative agreement.

What it unlocks is the agreement itself, not the drug rules — § 30-7-15a's Schedule I bar and three-day narcotic cap still apply afterwards.

The section names no separate certificate; the authorization follows the application.

And the exit is durable but not unconditional: by order arising out of its complaint process, the board may require a return to a collaborative agreement for a licensee's rehabilitation or public protection.

The counterpart is a collaborating physician licensed in good standing, and the agreement is written.

It must include mutually agreed guidelines or protocols for prescriptive authority as they apply to the APRN's clinical practice, statements of individual and shared responsibilities, periodic and joint evaluation of prescriptive practice, and periodic joint review and updating of the protocols.

Before applying at all, the APRN must have completed forty-five contact hours of education in pharmacology and clinical management of drug therapy under a board-approved program, fifteen hours of which fall within the two-year period immediately prior to entering the prerequisite collaborative relationship, and meet the remaining eligibility items (age at least eighteen, good moral character, no addiction, no suspension, limitation or revocation in any jurisdiction, notarized application and fee).

Verification of the agreement is filed with the board, which forwards a copy to the board that licenses the physician.

The statute sections read set no physician ratio, no chart-review percentage and no meeting frequency; subsection (b) also grants prescribing under "applicable legislative rules", and those board rules were not among the sources read.

Say it plainly: a West Virginia PMHNP can prescribe Schedule II ADHD stimulants.

Section 30-7-15a contains only two schedule limits — Schedule I is barred outright, and a Schedule II narcotic may be prescribed up to a three-day supply, as provided in §60A-2-206.

The cap is narcotic-specific, so it does not reach the non-narcotic stimulants, and subsection (c) closes the list: no other limitations on APRN prescribing except those in §16-54-1 et seq.

The narcotic rule carries one narrow carve-out: an APRN in an institutional-review-board-approved clinical trial for the rural expansion of medication-assisted treatment for opioid use disorder may dispense for the trial's time frame after registering with the Board of Pharmacy — an exemption limited to one program, CTN-0102-XR, the same program § 60A-9-4 provides for.

Schedules III to V carry no APRN-specific day cap in this section.

A separate state controlled-substance registration was not located in the sources read.

A PMHNP registers with the DEA as a mid-level practitioner, and that registration covers only what West Virginia lets the NP prescribe.

A DEA form listing Schedules II to V does not override § 30-7-15a's Schedule I bar or the three-day Schedule II narcotic cap.

The same goes for telehealth: the DEA and HHS telemedicine flexibilities, extended through December 31, 2026, let registered practitioners prescribe remotely without an in-person medical evaluation, but they lift no West Virginia limit — § 30-7-15a's schedule caps apply to telehealth prescriptions too.

West Virginia's own telehealth rules were not among the sources read.

Re-check the federal layer near the end of 2026, when the extension expires.

West Virginia has not enacted the APRN Compact.

The compact takes effect only once seven states enact it, and as of September 2026 five had (Delaware, North Dakota, South Dakota, Utah and Wyoming), so no APRN holds a multistate APRN licence today.

The Nurse Licensure Compact is an RN compact and gives no nurse practitioner authority in another state.

To practise as a PMHNP in West Virginia you need West Virginia APRN licensure and certification — and prescriptive authority through § 30-7-15b, whether that means entering a collaborative agreement or applying on three years of documented collaborative practice.

The code site's bill-history list for § 30-7-15a names SB2028 in the 2024 Second Special Session, and the list for § 30-7-15b names HB4817 in the 2024 Regular Session.

Neither appears in the signed-bills lists the same pages display — the most recent signed bills there are Enrolled House Bill 214 (2022 Second Special Session) for § 30-7-15a and Enrolled House Bill 4334 (2016) for § 30-7-15b — so enactment was not verified as of the retrieval date.

The section texts quoted on this page are as displayed on code.wvlegislature.gov on September 24, 2026.

Check the West Virginia Legislature before assuming the rules are unchanged.